Key points are not available for this paper at this time.
Abstract Three novel 4‐aryl‐2‐(2‐(4‐fluorophenyl)‐2‐oxoethyl)‐6‐phenylpyridazin‐3(2 H )‐one derivatives were synthesized, and their chemical structures were established based on 1 H‐NMR, 13 C‐NMR, ESI‐HRMS, and FT‐IR spectral data. Their in vitro antibacterial activities were evaluated against Staphylococcus aureus MRSA (Gram‐positive isolate), Escherichia coli and Salmonella typhimurium (Gram‐negative isolates), and Pseudomonas aeruginosa and Acinetobacter baumannii (Gram‐negative nonfermenter isolates), and the results were compared with the standard drug “Amikacin”. The results showed that one of the compounds has good antibacterial activity against P. aeruginosa (MIC = 11.57 µM) and E. coli (MIC = 23.14 µM). In order to gain molecular insights into the compounds, their reactivity properties were studied using density functional theory (DFT), and molecular docking was carried out for the compounds with E. coli MurB protein receptors (2Q85).
Building similarity graph...
Analyzing shared references across papers
Loading...
Said Daoui
Cemal Parlak
Şahin Direkel
ChemistrySelect
UCLouvain
King Saud University
University of Johannesburg
Building similarity graph...
Analyzing shared references across papers
Loading...
Daoui et al. (Fri,) studied this question.
www.synapsesocial.com/papers/68e572b9b6db643587512a9a — DOI: https://doi.org/10.1002/slct.202402996
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: